Bentham Science Logo

Contents

Current Angiogenesis (Discontinued), Volume 3 - Number 2

Editorial


Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

, 3(2): 60 - 65

Halima Abahssain, Sakina Sekkate, Sihame Lkhoyaali, Patricia Pautier, Hind M’Rabti and Hassan Errihani


DOI: 10.2174/2211552802666140911001518




Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review

, 3(2): 73 - 79

Nabil Ismaili


DOI: 10.2174/2211552803666141003221604



Targeting Angiogenesis in Gastro-Intestinal Non Colorectal Cancers; A Review

, 3(2): 80 - 87

S.A. Brahmi, Y. Seddik and S. Afqir


DOI: 10.2174/2211552802666140820223621



Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates

, 3(2): 88 - 96

Fadi El Karak, Hampig Raphael Kourie, Ralph Chebib, Samer Tabchi, Alain Daher, Joseph Kattan and Marwan Ghosn


DOI: 10.2174/2211552802666140704164740



Targeting Angiogenesis in Soft Tissue Sarcomas

, 3(2): 97 - 106

S. Arifi and J.Y. Blay


DOI: 10.2174/2211552802666140825190422



Targeting Angiogenesis in Thyroid Cancer

, 3(2): 107 - 112

S. Lkhoyaali, S. Benhmida, M. Aitelhaj, M. Layachi, H. Abahssain, H.N. Ismaili and H. Errihani


DOI: 10.2174/2211552802666140716170521



Resistance to Antiangiogenic: Focus on Mechanisms

, 3(2): 113 - 118

Essadi Ismail, Lalya Issam, Kaddouri Said, Belbaraka Rhizlane, Qacif Hassan, Zyani Mohamed and Patricia Pautier


DOI: 10.2174/2211552802666140821203156





Webmaster Contact: info@benthamscience.net
Copyright © 2019 Bentham Science